Philips and VU Medical Center Amsterdam Sign Long Term Research Agreement

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHI) and the VU University Medical Center (VUmc, Amsterdam, the Netherlands) have signed an agreement to jointly research new multi-modality imaging solutions aimed at improving the early detection and treatment of diseases such as cancer and neurological and cardiovascular diseases.

By combining data from different imaging modalities to increase the visibility of structures of interest and by mapping biological processes such as metabolism onto these images, new multi-modality imaging solutions could help clinicians to determine the presence and extent of many diseases at an earlier stage. This diagnostic information could then help them to plan and guide minimally-invasive interventions. It is expected that such solutions will contribute to more timely and more personalized treatments for patients and thereby improve treatment success rates.

To this end, both parties will work on the development and validation of next-generation medical imaging procedures, with initial projects focusing on nuclear imaging, especially Positron Emission Tomography (PET), and optical imaging techniques. For these modalities, the joint research projects will explore novel imaging agents (disease-specific contrast agents and tracers) and develop dedicated software for quantitative image analysis and user-friendly data presentation. Research programs for other imaging modalities are currently being prepared.

"We are very excited about our collaboration with Philips," says Elmer Mulder, CEO of VUmc. "I am confident that VUmc's excellence in medical care and expertise in molecular imaging, combined with Philips' innovation in next-generation medical scanners, will result in further progress in improving the lives of patients suffering from devastating oncological, neurological and cardiovascular diseases."

"In view of today's complex challenges in healthcare, such as the aging population, the demand for improved quality of care and rising healthcare costs, partnerships are one of the key ways to address the issues," says Jim Beckett, Vice President Philips Healthcare and head of Philips' Clinical Research Program. "Although medical technologies have consistently proved to be a significant part of the solution, we must always start with the needs of patients and care providers. Together with VUmc, we will work strenuously on developing novel medical imaging solutions aimed at detecting diseases at an earlier stage and on developing treatments that are ever-more tailored to individual patients."

Related news articles:

About VU University Medical Center
VU University Medical Center's core business consists of patient care, scientific research, and education. Its pivotal points in care and research are cancer and immunity, the brain, movement, vital functions and extramural care. Each year 38,000 patients are admitted (including one-day admissions), well over 300,000 patients visit the Outpatients department and 40,000 arrive at the Accident and Emergency department. Approximately 2,000 medical students are in training here. Each year, VU University Medical Center produces around 2,000 scientific publications and reports based on the scientific research carried out here. This includes the results of thesis research projects being carried out by 100 PhD students.

VU University Medical Center is a member of the Dutch Federation of University Medical Centers (NFU). The NFU is a collaborative venture of the eight university medical centers (UMCs) in the Netherlands. Its overall objective is to promote the common interests of the UMCs. The other members of the NFU are the AMC (Academic Medical Center in Amsterdam), azM (University Hospital Maastricht), Erasmus MC (University Medical Center Rotterdam), LUMC (Leiden University Medical Center), UMCG (University Medical Center Groningen), UMC Utrecht (University Medical Center Utrecht) and UMC St Radboud (Radboud University Nijmegen Medical Center). A total of 60,000 staff are employed by the eight UMCs.

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 116,000 employees in more than 60 countries worldwide. With sales of EUR 23 billion in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...